Key player · Company profile

GlaxoSmithKline plc

Named as a key player in 264 of our reports, across 33 regions and countries.

Fastest-growing markets they play in

2023–2033 CAGR · estimates

  1. 1Digital Biomarkers (India) 38.5%
  2. 2HIV Drugs (India) 8.8%
  3. 3Gastrointestinal Drugs (India) 7.6%
  4. 4Asthma & COPD Drugs (India) 7%
  5. 5Epilepsy Drugs (India) 6.5%
  6. 6Anti-Depressants Drugs (India) 5.7%

Where they show up

  • Pharmaceuticals165
  • OTC & Nutraceuticals33
  • Healthcare Services33
  • Digital Health33

Geographies

GlaxoSmithKline plc's markets

Markets where GlaxoSmithKline plc is a key player, with the world market size
MarketCategoryWorld 2023CAGR
Gastrointestinal Drugs Pharmaceuticals$54 Bn4.6%
Asthma & COPD Drugs Pharmaceuticals$49.5 Bn4%
HIV Drugs Pharmaceuticals$30 Bn5.8%
Anti-Depressants Drugs Pharmaceuticals$18 Bn2.7%
Epilepsy Drugs Pharmaceuticals$9.6 Bn3.5%
Digital Biomarkers Digital Health$4.4 Bn35.5%
Alopecia areata Healthcare Services––
Weight Management Supplement OTC & Nutraceuticals––

Companies they compete with most

Named as key players in the same markets as GlaxoSmithKline plc (number of shared markets).

Merck & Co., Inc.4 shared markets Novartis AG4 shared markets Pfizer Inc.4 shared markets AstraZeneca3 shared markets Eli Lilly and Company3 shared markets F. Hoffmann-La Roche Ltd3 shared markets Johnson & Johnson3 shared markets Sanofi3 shared markets

Recent reports naming GlaxoSmithKline plc

Search all reports for GlaxoSmithKline plc All companies